CLINICAL_TRIALS
trial_result
· 2022-04-04
Clinical Trial Update: Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients [Phase 3]
Summary
Phase 3 trial comparing ferumoxytol to oral iron for anemia in hemodialysis patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AMAG Pharmaceuticals, Inc. | Conditions: Anemia | Phase 3 | Status: COMPLETED